查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
数位疗法:新时代的医疗
市场调查报告书
商品编码
1152310

数位疗法:新时代的医疗

Digital Therapeutics: A New Age Medicine
出版日期: | 出版商: BCC Research | 英文 61 Pages | 订单完成后即时交付

价格

全球数位疗法的市场规模，预计从2022年的40亿美元，2027年达到139亿美元，从2022年到2027年的在预测期间中显示28.1％的年复合成长率。

糖尿病的部门，预计从2022年的11亿美元，2027年达到39亿美元，在预测期间中以29.1％的年复合成长率成长。还有精神疾病、依赖症的部门，预计从2022年的9亿6,180万美元，2027年达到32亿美元，在预测期间中以27.0％的年复合成长率成长。

本报告提供全球数位疗法的市场调查，市场概要，市场成长的各种影响因素分析，法律规章、偿付环境，市场规模的变化、预测，各种区分、各地区/主要国家的明细，竞争环境，主要企业简介等彙整资讯。

目录

第1章 市场预测

  • 市场概述

第2章 摘要、亮点

第3章 市场概要

  • 概要
  • 数位疗法的演进
  • 法律规范
  • 偿付
  • 数位疗法的优点
  • 数位疗法的生态系统

第4章 市场动态

  • 影响市场的要素
  • 推动市场要素
  • 阻碍市场要素
  • 机会
  • COVID-19影响

第5章 数位疗法市场:各用途

  • 糖尿病
  • 精神疾病、依赖症
  • 心血管疾病
  • 神经疾病
  • 其他

第6章 数位疗法市场:各销售管道

  • B2B
  • B2C

第7章 数位疗法市场:各地区

  • 北美
  • 欧洲
  • 亚太地区
  • 其他地区

第8章 竞争情形、市场机会分析

  • 策略性举措
  • 竞争分析

第9章 企业简介

  • AKILI INTERACTIVE LABS INC.
  • BIG HEALTH
  • CLICK THERAPEUTICS
  • HAPPIFY
  • OMADA HEALTH INC.
  • OREXO AB
  • PEAR THERAPEUTICS
  • PROPELLER HEALTH
  • VOLUNTIS
  • WELLDOC

第10章 计划的范围、调查手法

Product Code: HLC259B

Highlights:

The global digital therapeutics market should reach $13.9 billion by 2027 from $4.0 billion in 2022 at a compound annual growth rate (CAGR) of 28.1% for the forecast period of 2022 to 2027.

Diabetes segment of the global digital therapeutics market is expected to grow from $1.1 billion in 2022 to $3.9 billion in 2027 at a CAGR of 29.1% for the forecast period of 2022 to 2027.

Psychiatry (including addiction) segment of the global digital therapeutics market is expected to grow from $961.8 million in 2022 to $3.2 billion in 2027 at a CAGR of 27.0% for the forecast period of 2022 to 2027.

Report Scope:

The current report covers the booming technology of digital therapeutics. It also investigates the current shift in trends away from conventional methods of treatment toward the advanced means offered by digital therapeutics. This report is an update of an earlier report of the same title but focuses on more in-depth information. This report offers a comprehensive analysis of the global digital therapeutics market. Segmentation is based on application and sales channels. Based on application, the market is segmented as diabetes, psychiatric and addiction, neurological, cardiovascular diseases, and others. Based on sales channel the market is segmented as business-to-consumer (B2C) and business-to-business (B2B). The regional markets covered are North America, Europe, Asia-Pacific, and the Rest of the World (RoW). For market estimates, data has been provided for 2019, 2020, and 2021 as the base year, 2022, and a forecast for 2027.

The report provides a detailed overview and analysis of the present and future global market for digital therapeutics. Industry growth drivers, restraints, and opportunities are also discussed in detail. The report also provides a competitive landscape, elaborative company profiles, and the impact of COVID-19 on the market. The report focuses on the companies that are developing and encouraging digital therapeutics technology and doing research to develop the technology further.

Report Includes:

  • A brief general outlook of the global market for digital therapeutics scenario
  • Analyses of the global market trends, with market revenue data from 2019 to 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
  • Highlights of the current and upcoming market potential for digital therapeutics, and areas of focus to forecast this market into various segments and subsegments
  • Updated information on market opportunities and drivers, key shifts and trends, regulations and industry specific challenges, and other factors that will shape this market demand in the coming years (2022-2027)
  • Identification of the companies best positioned to meet the demand owing to their proprietary technologies, product launches, mergers and acquisitions, and other market strategic advantages
  • Review of the technology landscape for digital therapeutics marketplace with emphasis on recently approved products as well as products under development or in different stages of clinical trials
  • Profile descriptions of the market leading participants, including Big Health, Happify, Omada Health Inc., Pear Therapeutics and Welldoc

Table of Contents

Chapter 1 Market Outlook

  • 1.1 Market Snapshot

Chapter 2 Summary and Highlights

Chapter 3 Market Overview

  • 3.1 Overview
  • 3.2 Evolution of Digital Therapeutics
  • 3.3 Regulatory Framework
  • 3.4 Reimbursement
  • 3.5 Benefits of Digital Therapeutics
  • 3.6 Digital Therapeutics Ecosystem

Chapter 4 Market Dynamics

  • 4.1 Factors Affecting the Digital Therapeutics Market
  • 4.2 Market Drivers
    • 4.2.1 Increasing Incidence of Chronic Diseases
    • 4.2.2 Increasing Investments
    • 4.2.3 Increasing Preventive Healthcare
    • 4.2.4 Cost-Effective
    • 4.2.5 Rising Use of mHealth Apps and Wearables
  • 4.3 Market Restraints
    • 4.3.1 Physician Adoption
    • 4.3.2 Data Privacy and Security Concerns
    • 4.3.3 Regulatory Approval
    • 4.3.4 Reimbursement
  • 4.4 Opportunities
    • 4.4.1 Growing Technology Innovations
  • 4.5 Impact of COVID-19

Chapter 5 Digital Therapeutics Market by Application

  • 5.1 Global Digital Therapeutics Market by Application
  • 5.2 Diabetes
  • 5.3 Psychiatric Conditions and Addictions
  • 5.4 Cardiovascular Diseases
  • 5.5 Neurological Diseases
  • 5.6 Other Diseases

Chapter 6 Digital Therapeutics Market by Sales Channel

  • 6.1 Business-to-Business (B2B)
  • 6.2 Business-to-Consumer (B2C)

Chapter 7 Digital Therapeutics Market by Region

  • 7.1 North America
  • 7.2 Europe
  • 7.3 Asia-Pacific
  • 7.4 Rest of the World

Chapter 8 Competitive Landscape and Analysis of Market Opportunities

  • 8.1 Strategic Initiatives
  • 8.2 Competitive Analysis

Chapter 9 Company Profiles

  • AKILI INTERACTIVE LABS INC.
  • BIG HEALTH
  • CLICK THERAPEUTICS
  • HAPPIFY
  • OMADA HEALTH INC.
  • OREXO AB
  • PEAR THERAPEUTICS
  • PROPELLER HEALTH
  • VOLUNTIS
  • WELLDOC

Chapter 10 Project Scope and Methodology

  • 10.1 Study Goals and Objectives
  • 10.2 Reasons for Doing This Study
  • 10.3 Scope of Report
  • 10.4 What's New in This Update?
  • 10.5 Information Sources
  • 10.6 Methodology
  • 10.7 Geographic Breakdown
  • 10.8 Analyst's Credentials
  • 10.9 BCC Custom Research
  • 10.10 Related BCC Research Reports

List of Tables

  • Summary Table A : Global Digital Therapeutics Market, Through 2027
  • Table 1 : Examples of Products of Digital Health, Medicine, and Therapeutics
  • Table 2 : Digital Therapeutics Products
  • Table 3 : Digital Health Apps Globally, 2015-2021
  • Table 4 : Global Market for Digital Therapeutics, Through 2027
  • Table 5 : Global Digital Therapeutics Market, by Application, Through 2027
  • Table 6 : Global Digital Therapeutics Market for Diabetes, by Region, Through 2027
  • Table 7 : Global Digital Therapeutics Market for Psychiatric Conditions and Addictions, by Region, Through 2027
  • Table 8 : Global Digital Therapeutics Market for Cardiovascular Diseases, by Region, Through 2027
  • Table 9 : Global Digital Therapeutics Market for Neurological Diseases, by Region, Through 2027
  • Table 10 : Global Digital Therapeutics Market for Other Diseases, by Region, Through 2027
  • Table 11 : Global Digital Therapeutics Market, by Sales Channel, Through 2027
  • Table 12 : Global Digital Therapeutics Market for B2B Sales Channel, by Region, Through 2027
  • Table 13 : Global Digital Therapeutics Market for B2C Sales Channel, by Region, Through 2027
  • Table 14 : Global Digital Therapeutics Market, by Region, Through 2027
  • Table 15 : Mergers and Acquisitions, 2020-2022

List of Figures

  • Summary Figure A : Global Digital Therapeutics Market, 2019-2027
  • Figure 1 : Differences between Digital Health, Digital Medicine, and Digital Therapeutics
  • Figure 2 : Digital Therapeutics Composition
  • Figure 3 : Digital Therapeutics: Key Milestones
  • Figure 4 : Digital Therapeutics: Stakeholders Benefits
  • Figure 5 : Global Digital Therapeutics Market, by Application, 2019-2027
  • Figure 6 : Global Digital Therapeutics Market Shares, by Application, 2021
  • Figure 7 : Global Incidence of People Living with Diabetes Aged 20-79 Years, by Region, 2021, 2030, and 2045
  • Figure 8 : Global Digital Therapeutics Market for Diabetes, by Region, 2019-2027
  • Figure 9 : Global Digital Therapeutics Market for Psychiatric Conditions and Addictions, by Region, 2019-2027
  • Figure 10 : Share of Heart Disease Deaths in the U.S., by Disease Type, 2021
  • Figure 11 : Global Digital Therapeutics Market for Cardiovascular Diseases, by Region, 2019-2027
  • Figure 12 : Global Digital Therapeutics Market for Neurological Diseases, by Region, 2019-2027
  • Figure 13 : Global Digital Therapeutics Market for Other Diseases, by Region, 2019-2027
  • Figure 14 : Global Digital Therapeutics Market, by Sales Channel, 2019-2027
  • Figure 15 : Global Digital Therapeutics Market for B2B Sales Channel, by Region, 2019-2027
  • Figure 16 : Global Digital Therapeutics Market for B2C Sales Channel, by Region, 2019-2027
  • Figure 17 : Global Digital Therapeutics Market, by Region, 2019-2027
  • Figure 18 : Global Digital Therapeutics Market Shares, by Region, 2021
  • Figure 19 : Global Digital Therapeutics Market Shares, 2021
  • Figure 20 : Orexo: Annual Revenue, 2019-2021
  • Figure 21 : Pear Therapeutics: Annual Revenue, 2020 and 2021